The Diskus® inhaler. A review of its pharmaceutical and clinical performance

Clinical Drug Investigation

Volumn 18, Issue 4, 1999, Pages 287-296

  Chrystyn, Henry ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; SALBUTAMOL; SALMETEROL; SALMETEROL PLUS FLUTICASONE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0032710911     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918040-00005     Document Type: Article

References (83)

1. Cyr TD, Graham SJ, Li YY, et al. Low first-spray drug content in albuterol metered dose inbalers. Pharm Res 1991; 8: 658-60
2. Crompton GK. Problems patients have using pressurised aerosol inhalers. Eur J Respir Dis Suppl. 1982: 119: 101-4
3. Paterson JC, Crompton GK. Use of pressurised aerosols by asthmatic patients. BMJ 1976; 1: 76-7
4. O'Callaghan C, Barry P. Spacer devices in the treatment of asthma. BMJ 1997; 314 (7087): 1061-2
5. Hardy JG, Jausja AK, Frier M, et al. A small volurne spacer for use with a breath operated pressurised metered dose inhaler. Int J Pharm 1996; 142; 129-33
6. June DS, Schulz DW. Improved performance of CFC-free aerosol MDIs. J Aerosol Med 1995; 8: 91
7. Leach CL. Improved delivery of inhaled steroids to the lungs and small airways. Respir Med 1998; 92 Suppl. A: 3-8
8. Harrison CI, Colice GL, Donnell D, et al. Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: A 14-day dose-response study. J Pharm Pharmacol 1999; 51: 263-9
9. British Thoracic Society, The National Asthma Campaign. The Royal College of Physicians of London, et al. The British guidelines on asthma management 1995, review and position statement. Thorax 1997; 52 Suppl. 1: S1-S21
10. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. National Institutes of Health. National Heart Lung and Blood Institute, NIH publication no. 96-3659B, Nov 1998
11. Malton A, Sumby BS, Dandiker Y. A comparison of in-vitro drug delivery from salbutamol Diskus and terbutaline Turbuhaler inhalers. J Pharm Med 1996; 6: 35-48
12. Malton A, Sumby BS, Smith IJ. A comparison of in-vitro drug delivery from two multi-dose powder inhalation devices. Eur J Clin Res 1995; 7: 177-93
13. Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998; 92 (1): 105-10
14. Ashurst IC, Prime D, Haywood P. Development of a dry powder inhaler device containing a combination of salmeterol and fluticasone propionate. Eur Respir J 1998; 12 (28); 93s
15. Clark AR, Hollingworth AM. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - Implications for in vitro testing. J Aerosol Med 1993; 6: 99-110
16. Barrowcliffe J, McGlynn P, Tickle S, et al. The in vitro Evaluation of a Novel Multi-dose Dry Powder Inhaler. Drug Delivery to the Lungs VII. London: The Aerosol Society, 1996; 82-5
17. Barrowcliffe J. McGlynn P, Rutcliffe S, et al. Beclomethasone Dipropionate (BDP) Clickhaler™: in vitro Performance of a Steroid Novel Dry Powder Inhaler. Drug Delivery to the Lungs VIII. London: The Aerosol Society, 1997; 125-8
18. Brindley A, Sumby B, Smith IJ. The characterisation of inhalation devices by an inhalation simulator: The electronic lung. J Aerosol Med 1994; 7 (2); 197-200
19. Burnell PKP, Malton A, Reavill K, et al. Design, validation and initial testing of the electonic lung. J Aerosol Sci 1998; 29(8): 1011-25
20. Prime D, Parks PA, Haywood PA, et al. The Flixotide™ Diskus, a new multi-dose powder inhaler - in-vitro evaluation using an inhalation simulator. J Aerosol Med 1995; 8: 137
21. Bisgaard H, Klug B, Sumby BS, et al. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur Respir J 1998; 11: 1111-5
22. Johal B, Gibson GJ, Small T, et al. Use of inhalation profiles from patients with severe obstructive lung disease using the Diskus inhaler and Turhuhaler inhaler to evaluate device performance ex vivo. Eur Respir J 1997; 10 (25): 258s
23. Conway J, Smith S, Schreiber J, et al. Comparison of peak pressure drops through powder inhalers drug inspiration at maximum flow rate. Am J Respir Crit Care Med 1996; 153: A59
24. Richards R, Saunders M. Need for a comparative standard for dry powder inhalers. Thorax 1993; 48; 1186-7
25. Johnson S, Miles JF, Weir DC, et al. Turhuhaler: Objective assessment of patient generated flow. Thorax 1996; 51 Suppl. 3: A75
26. Chrystyn H, James L, Hawksworth GM. The inhalation rate of asthmatics with a Turbohaler when collecting their prescriptions from a community pharmacy. Am J Respir Crit Care Med 1998; 157; A636
27. Dewar MH, Jamieson A, McLean A, et al. Peak inspiratory flow through the Turhuhaler™ in chronic obstructive airways disease. Respir Med 1999; 93: 342-4
28. Nantel NP, Newhouse MT. Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in paedratric patients with asthma. J Aerosol Med 1999; 12 (2): 55-8
29. Prime D, Slater AL, Haywood PA, et al, The Flixotide™ Diskus™ a new multi-dose powder inhaler - Consistency of dose and fine particle mass, protection from moisture. J Aerosol Meal 1995; 8: 138
30. Meakin BJ, Cainey JM, Woodcock PM. Simulated 'in-use' and 'mis-use' aspects of the delivery of terbutaline sulphate from Bricanyl Turbuhaler™ dry powder inhalers. Int J Pharm 1995; 119: 103-8
31. Devadason SG, Everard ML, Le Souéf PN. Handling the Turbuhaler roughly affects drug output. Am J Respir Crit Care Med 1996; 153: A59
32. Barry PW. Problems with Inhalation Drug Delivery. PhD thesis. University of Leicester, 1999
33. Agdi A, Garren J. Pulmonary delivery of peptide drugs: Effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers. Pharm Res 1990; 7: 565-9
34. Olsson B, Asking L, Borgström L, et al. Effect of inlet throat on the correlation between fine particle dose and lung depositon. In: Dalby RN, Byron PR, Farr ST, editors. Respiratory Drug Delivery V. Phoenix USA: Interpharm Press, 1996; 273-81
35. Newman S, Steed K, Hooper G, et al. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurised metered dose inhalers. Pharm Res 1995; 12: 231-6
36. Borgström L, Newman S. Total and regional lung deposition of terbutaline sulphate via a pressurised MDI or via a Turbuhaler. Int J Pharm 1993; 97: 47-53
37. Johnson M, Newman SP, Bloom R, et al. Delivery of albuterol and ipratropium bromide from 2 nebuliser systems in chronic stable asthma. Chest 1989; 96: 1-10
38. Newman SP, Talalce N, Clarke SW. Salbutamol aerosol delivery in man with the Rondo Spacer. Acta Therapcutica 1991; 17: 49-58
39. Pitcaim GR, Lankinen T, Valkila E, et al. Lung deposition of salbutamol from the Leiras Metered Dose Powder Inhaler. J Aerosol Med 1995; 8: 307-11
40. Ross DL, Schulz RK. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI). J Aerosol Med 1996; 2: 215-26
41. Dolovich M, Ryan G, Newhouse M. Aerosol penetration into the lung: Influeuce on airway responses. Chest 1981; 80: 834-6
42. Zainudin BMZ, Biddiscombe M, Tolfree SEJ, et al. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 1990; 45: 469-73
43. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtype in the human lung. Am Rev Respir Dis 1989; 132: 541-7
44. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: Correlation with receptor autoradiography. Eur J Pharmacol 1991; 206: 133-8
45. Barnes PJ, Beta-adrenergic receptors and their regulators. Am J Respir Crit Care Med 1995; 152: 838-60
46. 2 agonists and anticholinergic aerosols in patients with severe airflow obstruction. Thorax 1996: 51: 977-80
47. Zanen P, Go TL, Lammers J-WJ. The optimal particle size for β2-adrenergic aerosols in mild asthmatics. Int J Pharm 1994; 107: 211-7
48. Faul J, Leonard C, Tourney VJ. et al. Lung immanopathology in cases of sudden asthmatic death. Eur Respir J 1997; 10: 301-7
49. Carroll N, Elliot A, Morton A, et al. The structure of large and small airways in non fatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-10
50. Dunnill MS. The pathology of asthma with special reference to change in bronchial mucosa. J Clin Pathol 1960; 13: 27-33
51. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the lungs and small airways of asthmatics. Eur Respir J 1997; 10: 292-300
52. Hamid QA, Ying Lee S, Minshall E, et al. Immunocytochemical study of inflammation in airways of surgically restricted lungs from asthmatic and non-asthmatic subjects. J Allergy Clin Immunol 1996; 97: 355
53. Kraft M, Djukanovic R, Wilson S. et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-10
54. Borgström L, Asking L, Beckman O. et al. Dose Variation within and between Individuals with Different Inhalation Systems. Respiratory Drug Delivery V. Buffalo Grove: Interpharm Press Inc, 1996: 19-24
55. Borgström L, Bengtsson T, Derom E, et al. Variability within and between patients of lung deposition of terbutaline inhaled via a pMDI or Turbuhaler. Am J Respir Crit Care Med 1999; 159 (3): A118
56. Gunawardena KA, Clay MM, Jenkins MM. The Diskus/Accuhaler multi-dose powder inhaler for the delivery of salmeterol in adult asthmatics. Br J Clin Res 1995; 6: 57-61
57. Lumry W, Schaumberg J, Reilly D, et al. Inhaled salmeterol powder administered via Diskus multi-dose powder inhaler or Rotadisk Diskhaler for treatment of asthma. Ear Respir J 1995; 8 Suppl. 19: 426s
58. Boulet LP, Cowrie R, Johnston P, et al. Comparison of Diskus Inhaler™, a new multi-dose powder inhaler, with Diskhaler™ Inhaler for the delivery of salmeterol to asthmatic patients. J Asthma 1995; 32: 429-36
59. Cater JI, Vare M, Peters WS, et al. Comparison of the efficacy of fluticasone propionate given twice daily via the Diskus/Accuhaler inhaler and the Diskhaler inhaler in patients with asthma. Eur Respir J 1995; 8 Suppl. 19: 427s
60. Pover GM, Langdon CG, Jones SR, et al. Evaluation of a breath-operated powder inhaler. J Int Med Res 1988; 16: 201-3
61. Stallaert R, Prins J. A comparison of the metered-dose inhaler and dry powder Diskhaler inhaler formulations of salmeterol in mild and moderate asthmatics. Schweiz Med Wochenschr 1991; 121 (40) Suppl. II: 23
62. Lundbäck B, Dahl R, DeJonghe M. et al. A comparison of fluticasone propionate when developed by either the metered dose inhaler or the Diskhaler inhaler in the treatment of mild to moderate asthma. Eur J Clin Rcs 1994; 5: 11-9
63. Glaxo Wellcome Study Report Flit 69; Data on File. Glaxo Wellcome UK
64. -1) administered by pressurised inhaler. Respir Med 1993; 87: 609-20
65. Bousquet J, Tesserand B, Medley HV. Double-blind parallel group study to compare the long term clinical effect and safety of two different methods of administering inhaled fluticasone dipropionate in chronic severe asthmatic patients. Eur Respir J 1995; 8 Suppl. 19: 427s
66. Glaxo Wellcome Study Report Flit 12; Data on File. Glaxo Wellcome UK
67. Fuller RW, Prime D, Sharma RK. What is the clinical relevance of in-vitro pharmaceutical data? Chest 1996; 110 Suppl.: 86s
68. Drepaul BA, Payler DK, Qualtrugh JE, et al. Becotide or Beclodisks? A controlled study in general practice. Clin Trials J 1989; 26: 335-44
69. Williams J. Ease of handling and clinical efficacy of fluticasone propionate Accuhalerr™/Diskus™ inhaler compared with the Turbuhaler inhaler in paediatric patients. Br J Clin Prac 1997; 51: 147-53
70. Burdon J, Droszez W, Jones R, et al. Comparison of the efficacy and case of handling of salmeterol and terbutaline powder inhalers. Int J Clin Pract 1998; 52 (2): 85-8
71. Nielsen KG, Auk IL, Bojsen K. et al. Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 1998; 11: 350-4
72. Newman SP, Morén F, Trufast E, et al. Terbutaline sulphate Turbuhaler: Effect of inhaled flow rate on drug deposition and efficacy. Int J Pharm 1991; 74: 209-13
73. Engel T, Scharling B, Skoustead B, et al. Effect, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from dry powder inhaler device at different inhalation flows and volumes. Br J Clin Phamacol 1992; 33: 439-44
74. Borgström L, Bondesson E, Morén E, et al. Lung deposition of budesonide inhaled via a Turbuhaler. A comparison with terbutaline sulphate. Eur Resp J 1994; 7: 69-73
75. Newhouse MT, Nantel NP, Chambers CB, et al. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Chest 1999; 115: 952-6
76. Clark DJ, Lipworth BJ. Dose response of inhaled drugs in asthma; an update. Clin Pharmacokinet 1997; 32: 59-74
77. Ayres AC, Bateman ED, Lundbäck B, et al. High dose fluticasone propionate 1 mg daily versus fluticasone propionate 2mg/day and hudesonide 1.6mg/day in patients with chronic severe asthma. Eur Respir J 1995; 8: 579-86
78. van den Berg NJ, Ossip M, Hederos CA, et al. Combined salmeterol xinafoate and fluticasone propionate (50/100 μg strength) BD via one Diskus™ (Accuhaler™) inhaler compared with salmeterol xinafoate 50 μg and fluticasone propionate 100 μg BD via two separate Diskus inhalers. Eur Resp J 1998; 12 Suppl. 28: 157
79. Picters WR, Steinmetz KO, Aubier M, et al. Effectiveness of a new salmeterol/fluticasone propionate (50/500 μg) combination inhaler in patients with reversible airways obstruction. Eur Resp J 1998; 12 (28 Suppl.): 35-6
80. Schlaeppi M, Edwards K, Fuller RW, et al. Patient perception of the Diskus Inhaler. A Comparison with the Turbuhaler inhaler. Br J Clin Pract 1996; 50: 14-9
81. Luyt D, Vermeulen J, Johnson L, et al. A comparison of the ease of handling of the Diskus/Accuhaler inhaler and the Turbuhaler inhaler in children aged 6-12 years with asthma. J Aerosol Med 1995; 8: 105
82. Sharma RK, Edwards K, Hallett C, et al. Perception among paediatric patients of the Diskus® Inhaler, a novel multi-dose powder inhaler for use in the treatment of asthma. Clin Drug Invest 1996; II: 143-5
83. Venahles TA. A multicentre study in general practice to compare the efficacy and tolerability of inhaled salmeterol xinofoate and terbutaline in the treatment of asthma. Br J Clin Res 1992; 3:125-36